SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $172M invested in SPDR S&P Pharmaceuticals ETF in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
Holders
80
Holding in Top 10
–
Calls
$491K
Puts
–
Top Buyers
| 1 | +$5.27M | |
| 2 | +$3.32M | |
| 3 | +$3.16M | |
| 4 |
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Tel Aviv,
Israel
|
+$3.06M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.63M |
Top Sellers
| 1 | -$8.49M | |
| 2 | -$4.33M | |
| 3 | -$2.78M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.78M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.69M |